|
UFP 803
|
|
879497-82-2
|
|
H-His-Phe-OH
|
|
16874-81-0
|
|
Ac-D-Arg-Cys-Glu-His-D-Phe-Arg-Trp-Cys-NH2(Disulfide bridge：Cys2-Cys8)
|
|
819048-44-7
|
|
MC-Val-Cit-PAB
|
|
159857-80-4
|
|
Neuronostatin-13 human
|
|
1096485-24-3
|
|
CGP 42112
|
|
127060-75-7
|
|
PG106
|
|
944111-22-2
|
|
HAEGTFTSDVS
|
|
864915-61-7
|
|
R18
|
|
211364-78-2
|
|
CyclosporinA-Derivative2
|
環(huán)孢菌素A-衍生物2
|
156047-45-9
|
|
Huwentoxin XVI
|
|
1600543-88-1
|
|
HEX3
|
|
688805-40-5
|
|
D-γ-Glutamyl-D-glutamicacid
|
|
4553-17-7
|
|
H-D-Leu-Tyr-OH
|
D-亮氨酰-L-酪氨酸水合物
|
3303-29-5
|
|
GR 94800
|
|
141636-65-9
|
|
PKC β pseudosubstrate
|
PKC抑制劑多肽
|
172308-76-8
|
|
Fmoc-Val-Cit-OH
|
(S)-2 - ((S)-2 - (((((9H-芴-9-基)甲氧基)羰基)氨基)-3-甲基丁酰氨基
|
159858-21-6
|
|
FSL1
|
|
322455-70-9
|
|
Pam2CSK4
|
|
868247-72-7
|
|
α-Bungarotoxin
|
Α-金環(huán)蛇毒
|
11032-79-4
|
|
GamaGlu-Val-Gly
|
|
38837-70-6
|
|
H-Val-Pro-Pro-OH
|
|
58872-39-2
|
|
H-Leu-Pro-OH hydrochloride
|
|
87178-63-0
|
|
Phe-Gly-Gly
|
L-苯丙氨酰甘氨酰甘氨酸
|
23576-42-3
|
|
MSG606
|
|
1416983-77-1
|
|
ALX40-4C
|
|
143413-49-4
|
|
C21
|
|
1229236-78-5
|
|
Rac1InhibitorW56
|
|
1095179-01-3
|
|
Gly6
|
|
3887-13-6
|
|
gamma-Glu-leu
|
N-L-gamma-谷氨酰-L-亮氨酸
|
2566-39-4
|
|
ANQ 11125
|
|
153966-48-4
|
|
Alarin (Human)
|
|
909409-86-5
|
|
Lei-Dab 7
|
|
1061556-49-7
|
|
Cyclo(phenylalanylprolyl)
|
六氫-3-(苯基甲基)吡咯并[1,2-A]吡嗪-1,4-二酮
|
14705-60-3
|
|
TC14012
|
|
368874-34-4
|
|
H-Ala-Ala-Tyr-OH
|
|
67131-52-6
|
|
CTCE-9908
|
|
1030384-98-5
|
|
CART(55-102)(human)
|
|
214050-22-3
|
|
H-Ser-Ser-OH
|
|
6620-95-7
|
|
YAP-TEAD-IN-1
|
|
1659305-78-8
|
|
Oligopeptide P11-4
|
|
593266-60-5
|
|
BimBH3,PeptideIV
|
|
721885-31-0
|
|
Competence-StimulatingPeptide-12261
|
|
1235882-91-3
|
|
RC-3095
|
|
138147-78-1
|
|
p5 Ligand for Dnak and DnaJ
|
|
209518-24-1
|
|
Cotadutide acetate
|
|
1686108-82-6
|
|
Myomodulin
|
|
110570-93-9
|
|
gamma-DGG
|
6729-55-1
|
|
p2Ca
|
|
142606-55-1
|
|
Parstatin (human)
|
血管生成抑制劑
|
1065755-99-8
|
|
N-Acetyl-O-phosphono-Tyr-GluDipentylamide
|
|
190078-50-3
|
|
Tetraglycine
|
四聚甘胺酸
|
637-84-3
|
|
(D)-PPA1
|
|
1620813-53-7
|
|
AtPep3
|
|
902781-14-0
|
|
D-Phe2]-VIP (human, bovine, porcine, rat)
|
|
104051-15-2
|
|
Rapastinel
|
雷帕替奈
|
117928-94-6
|
|
CDK2
|
|
255064-79-0
|
|
WKYMVM
|
|
187986-17-0
|
|
RS 09
|
|
1449566-36-2
|
|
JAG-1,scrambled
|
|
402941-23-5
|
|
PG931
|
|
667430-81-1
|
|
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm
|
|
1647119-71-8
|
|
TRV-120027
|
|
1234510-46-3
|
|
H-Cys-Gly-Gly-Arg-Gly-Asp-OH
|
|
1260223-44-6
|
|
Prepro VIP (111-122) (human)
|
|
123025-94-5
|
|
PL017
|
N-Me-phe（3）-嗎啡肽
|
83397-56-2
|
|
A-71915TFA
|
|
132956-87-7
|
|
H-Ala-Trp-Ala-OH
|
|
126310-63-2
|
|
Dp-Cl-Phe6，Leu17]-VIP
|
|
102805-45-8
|
|
AUNP-12
|
調(diào)節(jié)劑多肽
|
1353563-85-5
|
|
D-D-D-D-D
|
|
124219-00-7
|
|
H-His-Pro-OH
|
|
20930-58-9
|
|
Catestatin
|
酪蛋白肽
|
142211-96-9
|
|
CyclosporinD
|
環(huán)孢霉素D
|
63775-96-2
|
|
N-Acetyl-O-phosphono-Tyr-Glu-Glu-Ile-Glu
|
|
159439-02-8
|
|
HPV16-E711-20 epitope
|
|
160040-04-0
|
|
CyclotraxinB
|
|
1203586-72-4
|
|
SV40 T-Ag-derived NLS peptide
|
|
105425-98-7
|
|
CysHHC10
|
|
1408311-03-4
|
|
Tyroserleutide hydrochloride
|
|
852982-42-4
|
|
Nemifitide di
|
|
204992-09-6
|
|
Rac1 Inhibitor F56, control peptide
|
|
1315378-77-8
|
|
P60c-src Substrate II, Phosphorylated
|
|
284660-72-6
|
|
Difelikefalin Impurities
|
H-D-Phe-D-Phe-D-Leu-D-Lys-Pip-OH
|
1024828-77-0
|
|
JMV 449
|
|
139026-66-7
|
|
CyclosporinA-Derivative1
|
|
1487360-85-9
|
|
Fz7-21
|
|
2247635-23-8
|
|
TAT-GluA23Y
|
|
1404188-93-7
|
|
ELA-21(human)
|
|
2245073-05-4
|
|
Toxic Shock SyndroMe Toxin-1 (TSST-1) (58-78）
|
|
137593-46-5
|
|
SIYRY
|
|
178561-37-0
|
|
Urocortin II,mouse
|
UROCORTIN II (小鼠)
|
330648-32-3
|
|
LAH4
|
|
184776-51-0
|
|
P60c-src Substrate II
|
|
168781-78-0
|
|
Hsp70-derivedoctapeptide
|
|
736171-62-3
|
|
Apraglutide
|
|
1295353-98-8
|
|
Pressinoic Acid
|
|
35748-51-7
|
|
OVAG4peptide
|
|
148274-82-2
|
|
Dynamin inhibitory peptide
|
動力抑制肽
|
251634-21-6
|
|
MMP-1 Substrate I, fluorogenic
|
|
135662-04-3
|